Discontinuous counterimmunoelectrophoresis in the diagnosis of antibiotic-associated colitis

John Fremont Fisher, Francis J. Tedesco, David H. Johnson, J. Peter Rissing, Carol A. Walker, Rose C. Trincher, Linda Howard, Thomas Buxton, John F. Agel

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Discontinuous counterimmunoelectrophoresis (DOE) was employed to detect the toxin of Clostridium difficile, etiologic antibiotic-associated colitis (AAC), in bacteria-free stool filtrates from 51 patients with diarrhea. Stool samples from 31 patients contained C. difficile toxin as determined by tissue-culture assay. A positive result was obtained by DCIE in 20 of the 31 patients (65%) and was influenced by the titer of toxin present. When toxin was present by tissue-culture assay in a dilution of 10-2 (11 samples), DCIE was positive in only 2 (18%). However, DCIE yielded positive results in 18 of the 20 samples (90%) containing toxin titers ≥10-3. The combination of DCIE and sigmoidoscopy or colonoscopy was superior to either alone in the diagnosis of AAC irrespective of the toxin titer. Nine of 11 patients (82%) whose stool samples contained C. difficile toxin in a dilution of ≥10-2 were recognized by DCIE, endoscopy, or both. In stool samples containing toxin in titers ≥10-3, no falsenegative results were encountered (sensitivity = 100%). Thus, 29 of 31 patients whose stool samples contained C. difficile toxin were identified when the results of DCIE and endoscopical examination were combined (sensitivity 93.5%). Neither endoscopical examination nor DCIE yielded positive results in the 20 patients whose stool samples lacked C. difficile toxin (specificity = 100%). DCIE is a rapid, moderately sensitive, and specific method for detecting C. difficile toxin. When DCIE is combined with endoscopy, the vast majority of patients requiring specific therapy for AAC can be identified.

Original languageEnglish (US)
Pages (from-to)253-256
Number of pages4
JournalJournal of Clinical Gastroenterology
Volume4
Issue number3
DOIs
StatePublished - Jan 1 1982

Fingerprint

Counterimmunoelectrophoresis
Pseudomembranous Enterocolitis
Clostridium difficile
Endoscopy
Sigmoidoscopy
Colonoscopy
Diarrhea
Bacteria

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Discontinuous counterimmunoelectrophoresis in the diagnosis of antibiotic-associated colitis. / Fisher, John Fremont; Tedesco, Francis J.; Johnson, David H.; Rissing, J. Peter; Walker, Carol A.; Trincher, Rose C.; Howard, Linda; Buxton, Thomas; Agel, John F.

In: Journal of Clinical Gastroenterology, Vol. 4, No. 3, 01.01.1982, p. 253-256.

Research output: Contribution to journalArticle

Fisher, John Fremont ; Tedesco, Francis J. ; Johnson, David H. ; Rissing, J. Peter ; Walker, Carol A. ; Trincher, Rose C. ; Howard, Linda ; Buxton, Thomas ; Agel, John F. / Discontinuous counterimmunoelectrophoresis in the diagnosis of antibiotic-associated colitis. In: Journal of Clinical Gastroenterology. 1982 ; Vol. 4, No. 3. pp. 253-256.
@article{1b46795ef5674b2b95d07ae5f77da087,
title = "Discontinuous counterimmunoelectrophoresis in the diagnosis of antibiotic-associated colitis",
abstract = "Discontinuous counterimmunoelectrophoresis (DOE) was employed to detect the toxin of Clostridium difficile, etiologic antibiotic-associated colitis (AAC), in bacteria-free stool filtrates from 51 patients with diarrhea. Stool samples from 31 patients contained C. difficile toxin as determined by tissue-culture assay. A positive result was obtained by DCIE in 20 of the 31 patients (65{\%}) and was influenced by the titer of toxin present. When toxin was present by tissue-culture assay in a dilution of 10-2 (11 samples), DCIE was positive in only 2 (18{\%}). However, DCIE yielded positive results in 18 of the 20 samples (90{\%}) containing toxin titers ≥10-3. The combination of DCIE and sigmoidoscopy or colonoscopy was superior to either alone in the diagnosis of AAC irrespective of the toxin titer. Nine of 11 patients (82{\%}) whose stool samples contained C. difficile toxin in a dilution of ≥10-2 were recognized by DCIE, endoscopy, or both. In stool samples containing toxin in titers ≥10-3, no falsenegative results were encountered (sensitivity = 100{\%}). Thus, 29 of 31 patients whose stool samples contained C. difficile toxin were identified when the results of DCIE and endoscopical examination were combined (sensitivity 93.5{\%}). Neither endoscopical examination nor DCIE yielded positive results in the 20 patients whose stool samples lacked C. difficile toxin (specificity = 100{\%}). DCIE is a rapid, moderately sensitive, and specific method for detecting C. difficile toxin. When DCIE is combined with endoscopy, the vast majority of patients requiring specific therapy for AAC can be identified.",
author = "Fisher, {John Fremont} and Tedesco, {Francis J.} and Johnson, {David H.} and Rissing, {J. Peter} and Walker, {Carol A.} and Trincher, {Rose C.} and Linda Howard and Thomas Buxton and Agel, {John F.}",
year = "1982",
month = "1",
day = "1",
doi = "10.1097/00004836-198206000-00010",
language = "English (US)",
volume = "4",
pages = "253--256",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Discontinuous counterimmunoelectrophoresis in the diagnosis of antibiotic-associated colitis

AU - Fisher, John Fremont

AU - Tedesco, Francis J.

AU - Johnson, David H.

AU - Rissing, J. Peter

AU - Walker, Carol A.

AU - Trincher, Rose C.

AU - Howard, Linda

AU - Buxton, Thomas

AU - Agel, John F.

PY - 1982/1/1

Y1 - 1982/1/1

N2 - Discontinuous counterimmunoelectrophoresis (DOE) was employed to detect the toxin of Clostridium difficile, etiologic antibiotic-associated colitis (AAC), in bacteria-free stool filtrates from 51 patients with diarrhea. Stool samples from 31 patients contained C. difficile toxin as determined by tissue-culture assay. A positive result was obtained by DCIE in 20 of the 31 patients (65%) and was influenced by the titer of toxin present. When toxin was present by tissue-culture assay in a dilution of 10-2 (11 samples), DCIE was positive in only 2 (18%). However, DCIE yielded positive results in 18 of the 20 samples (90%) containing toxin titers ≥10-3. The combination of DCIE and sigmoidoscopy or colonoscopy was superior to either alone in the diagnosis of AAC irrespective of the toxin titer. Nine of 11 patients (82%) whose stool samples contained C. difficile toxin in a dilution of ≥10-2 were recognized by DCIE, endoscopy, or both. In stool samples containing toxin in titers ≥10-3, no falsenegative results were encountered (sensitivity = 100%). Thus, 29 of 31 patients whose stool samples contained C. difficile toxin were identified when the results of DCIE and endoscopical examination were combined (sensitivity 93.5%). Neither endoscopical examination nor DCIE yielded positive results in the 20 patients whose stool samples lacked C. difficile toxin (specificity = 100%). DCIE is a rapid, moderately sensitive, and specific method for detecting C. difficile toxin. When DCIE is combined with endoscopy, the vast majority of patients requiring specific therapy for AAC can be identified.

AB - Discontinuous counterimmunoelectrophoresis (DOE) was employed to detect the toxin of Clostridium difficile, etiologic antibiotic-associated colitis (AAC), in bacteria-free stool filtrates from 51 patients with diarrhea. Stool samples from 31 patients contained C. difficile toxin as determined by tissue-culture assay. A positive result was obtained by DCIE in 20 of the 31 patients (65%) and was influenced by the titer of toxin present. When toxin was present by tissue-culture assay in a dilution of 10-2 (11 samples), DCIE was positive in only 2 (18%). However, DCIE yielded positive results in 18 of the 20 samples (90%) containing toxin titers ≥10-3. The combination of DCIE and sigmoidoscopy or colonoscopy was superior to either alone in the diagnosis of AAC irrespective of the toxin titer. Nine of 11 patients (82%) whose stool samples contained C. difficile toxin in a dilution of ≥10-2 were recognized by DCIE, endoscopy, or both. In stool samples containing toxin in titers ≥10-3, no falsenegative results were encountered (sensitivity = 100%). Thus, 29 of 31 patients whose stool samples contained C. difficile toxin were identified when the results of DCIE and endoscopical examination were combined (sensitivity 93.5%). Neither endoscopical examination nor DCIE yielded positive results in the 20 patients whose stool samples lacked C. difficile toxin (specificity = 100%). DCIE is a rapid, moderately sensitive, and specific method for detecting C. difficile toxin. When DCIE is combined with endoscopy, the vast majority of patients requiring specific therapy for AAC can be identified.

UR - http://www.scopus.com/inward/record.url?scp=0020051281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020051281&partnerID=8YFLogxK

U2 - 10.1097/00004836-198206000-00010

DO - 10.1097/00004836-198206000-00010

M3 - Article

C2 - 7096958

AN - SCOPUS:0020051281

VL - 4

SP - 253

EP - 256

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 3

ER -